Viewing Study NCT01962532

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:36 PM
Ignite Modification Date: 2026-04-03 @ 6:15 PM
Study NCT ID: NCT01962532
Status: COMPLETED
Last Update Posted: 2019-05-15
First Post: 2013-07-26
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-42756493 in Patients With Advanced or Refractory Solid Tumors or Lymphoma
Sponsor: Janssen Research & Development, LLC
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Neoplasms View
None Lymphoma View
None Adenocarcinoma View
None Esophagogastric Junction View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Neoplasms View
None Lymphoma View
None Advanced or refractory solid tumors View
None Advanced or refractory lymphoma View
None Gastric adenocarcinoma View
None Gastroesophageal junctions View
None JNJ-42756493 View
None Pharmacokinetics View
None Japanese View
None Asian View
None Pharmacodynamics View